Value through Innovation22 October 2014

Boehringer Ingelheim Press Releases

See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.

Press Release Archive

26.03.2013

Boehringer Ingelheim and Eli Lilly and Company announce acceptance of European marketing authorisation application for investigational Type 2 Diabetes treatment empagliflozin*

- EX US & UK Medical Media Only
19.03.2013

Boehringer Ingelheim and Lilly initiate MARLINA-T2D™ clinical trial to evaluate use of Trajenta® (linagliptin) in patients with type 2 diabetes and albuminuria

- For Non-U.S. and Non-U.K. Media
18.03.2013

Boehringer Ingelheim Animal Health sponsors PCV2 research projects with more than 400,000 euro

11.03.2013

American College of Cardiology and Boehringer Ingelheim collaborate to advance physician education with focus on China in 2013

- For Non-US, Non-UK & Non-Canadian Media Only
11.03.2013

Pharmaco-invasive strategy including Metalyse® delivers comparable clinical outcomes to primary PCI for STEMI patients who could not undergo primary PCI within one hour from first medical contact

- For NON-U.S. Media Only
04.03.2013

Boehringer Ingelheim announces interim results from a Phase III trial in HIV patients co-infected with chronic hepatitis C

- For media outside of the U.S.A., UK and Canada only
28.02.2013

Rare disease day: Boehringer Ingelheim announces initiation of pivotal trial investigating volasertib* in patients with acute myeloid leukaemia

- For NON-US media only
25.02.2013

Healthcare Innovation World Cup: Call for Breakthrough Ideas to Tackle Diabetes

23.02.2013

Phase III results: tiotropium* Respimat® is effective in symptomatic asthma patients irrespective of their allergic status

21.02.2013

New findings from two studies support substantial benefit of Pradaxa® for prevention of recurrent deep vein thrombosis and pulmonary embolism

- For Non-US, Non-UK & Non-Canadian Media Only
14.02.2013

Preventing disease: One billion pigs vaccinated with Ingelvac CircoFLEX®

30.01.2013

FDA Advisory Committee Recommends Approval for Boehringer Ingelheim’s Olodaterol* for Maintenance Treatment of COPD

- For Media outside the U.S. and UK
23.01.2013

Boehringer Ingelheim and Ashoka Changemakers Launch Competition to Find Business Models that Transform Health Systems

17.01.2013

Boehringer Ingelheim and the EFSD call for grant applications in diabetes research

17.01.2013

Boehringer Ingelheim enrols first patients in pivotal Phase III interferon-free hepatitis C trial programme

- For media outside of the U.S.A., UK and Canada only
16.01.2013

U.S. FDA Grants Priority Review to Boehringer Ingelheim’s Afatinib* NDA for EGFR Mutation-Positive Advanced NSCLC

- For NON-U.S. Media Only
07.01.2013

Boehringer Ingelheim and Eli Lilly and Company announce positive top-line pivotal Phase III data results for empagliflozin

- EX US & UK. Medical Media Only.
07.01.2013

Lilly reassumes sole worldwide development and commercialization rights for novel basal insulin analog